TY - JOUR T1 - Large-scale implementation of pooled RNA-extraction and RT-PCR for SARS-CoV-2 detection JF - medRxiv DO - 10.1101/2020.04.17.20069062 SP - 2020.04.17.20069062 AU - Roni Ben-Ami AU - Agnes Klochendler AU - Matan Seidel AU - Tal Sido AU - Ori Gurel-Gurevich AU - Moran Yassour AU - Eran Meshorer AU - Gil Benedek AU - Irit Fogel AU - Esther Oiknine-Djian AU - Asaf Gertler AU - Zeev Rotstein AU - Bruno Lavi AU - Yuval Dor AU - Dana G. Wolf AU - Maayan Salton AU - Yotam Drier AU - The Hebrew University-Hadassah COVID-19 diagnosis team Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/07/2020.04.17.20069062.abstract N2 - Testing for active SARS-CoV-2 infection is a fundamental tool in the public health measures taken to control the COVID-19 pandemic. Due to the overwhelming use of SARS-CoV-2 RT-PCR tests worldwide, availability of test kits has become a major bottleneck. Here we demonstrate pooling strategies to perform RNA extraction and RT-PCR in pools, significantly increasing throughput while maintaining clinical sensitivity. We implemented the method in a routine clinical diagnosis setting of asymptomatic populations, and already tested 5,464 individuals for SARS-CoV-2 using 731 RNA extraction and RT-PCR kits. We identified six SARS-CoV-2 positive patients corresponding to 0.11% of the tested population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYotam Drier is supported by an Alon Fellowship and the Concern Foundation / American Friends of the Hebrew University Young Professorship Award.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data appear in the main text. ER -